The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The Platelet in Diabetes
Abstract
Accelerated atherosclerosis and the increased risk of thrombotic vascular events in diabetes may result from dyslipidemia, endothelial dysfunction, platelet hyperreactivity, an impaired fibrinolytic balance, and abnormal blood flow. There is also a correlation between hyperglycemia and cardiovascular (CV) events. The importance of platelets in the atherothrombotic process has led to investigation of using antiplatelet agents to reduce CV risk. A meta-analysis conducted by the Antiplatelet Trialists’ Collaboration demonstrated that aspirin reduced the risk of ischemic vascular events as a secondary prevention strategy in numerous high-risk groups, including patients with diabetes. Based on results from placebo-controlled randomized trials, the American Diabetes Association recommends low-dose enteric-coated aspirin as a primary prevention strategy for people with diabetes at high risk for CV events. Clopidogrel is recommended if aspirin allergy is present. There is occasionally a need for an alternative to aspirin or for additive antiplatelet therapy. Aspirin in low doses inhibits thromboxane production by platelets but has little to no effect on other sites of platelet reactivity. Agents such as ticlopidine and clopidogrel inhibit ADP-induced platelet activation, whereas the platelet glycoprotein (Gp) IIb/IIIa complex receptor antagonists block activity at the fibrinogen binding site on the platelet. These agents appear to be useful in acute coronary syndromes (ACSs) in diabetic and nondiabetic patients. A combination of clopidogrel plus aspirin was more effective than placebo plus standard therapy (including aspirin) in reducing a composite CV outcome in patients with unstable angina and non-ST segment elevation myocardial infarction. In a meta-analysis of six trials in diabetic patients with ACSs, intravenous GpIIb-IIIa inhibitors reduced 30-day mortality when compared with control subjects. Results from controlled prospective clinical trials justify the use of enteric-coated low-dose aspirin (81–325 mg) as a primary or secondary prevention strategy in adult diabetic individuals (aged >30 years) at high risk for CV events. Recent studies support the use of clopidogrel in addition to standard therapy, as well as the use of GpIIb-IIIa inhibitors in ACS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063 · cited 1×
“Diabetes increases the risk for coronary heart disease (CHD), stroke, and peripheral arterial disease (PAD) from twofold to fourfold (2,3).”
BackgroundBanting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,264
(2000) · PubMed · Cited by 2,095
Pearson, T. A., Blair, S. N., Daniels, S. R., Eckel, R. H., Fair, J. M., Fortmann, S. P., Franklin, B. A., Goldstein, L. B., Greenland, P., Grundy, S. M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000020190.45892.75 · Cited by 1,854
Long-Term Complications of Diabetes Mellitus
Nathan, D. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282306 · Cited by 1,495
The way I see it: House officers need formal career development
Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,143
Roncaglioni, M. C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03539-x · Cited by 999
Stability and Instability: Two Faces of Coronary Atherosclerosis: The Paul Dudley White Lecture 1995
Davies, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.8.2013 · Cited by 915
International Textbook of Diabetes Mellitus
(2004) · Wiley eBooks · doi:10.1002/0470862092 · Cited by 725
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
Bennett, C. L., Connors, J. M., Carwile, J. M., Moake, J. L., Bell, W. R., Tarantolo, S. R., McCarthy, L. J., Sarode, R., Hatfield, A. J., Feldman, M. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422402 · Cited by 643
Stein, B., Weintraub, W. S., Gebhart, S. S. P., Cohen-Bernstein, C. L., Grosswald, R., Liberman, H. A., Douglas, J. S., Morris, D. C., & King, S. B. (1995) · Circulation · doi:10.1161/01.cir.91.4.979 · Cited by 531
Kassoff, A. (1992) · JAMA · doi:10.1001/jama.1992.03490100090033 · Cited by 481
Kip, K. E., Faxon, D. P., Detre, K. M., Yeh, W., Kelsey, S. F., & Currier, J. W. (1996) · Circulation · doi:10.1161/01.cir.94.8.1818 · Cited by 452
Roffi, M., Chew, D. P., Mukherjee, D., Bhatt, D. L., White, J. A., Heeschen, C., Hamm, C. W., Moliterno, D. J., Califf, R. M., White, H. D., et al. (2001) · Circulation · doi:10.1161/hc4801.100029 · Cited by 428
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
Bhatt, D. L., Marso, S. P., Hirsch, A. T., Ringleb, P. A., Hacke, W., & Topol, E. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02567-5 · Cited by 409
Colwell, J. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.11.1767 · Cited by 401
Self-citationIncreased platelet aggregation in diabetes mellitus.
Kueh, Y. K., Bc, L., Chan, L., Thai, A. C., Kw, W., Lui, K. F., & Yeo, P. P. (1982) · PubMed · Cited by 326
Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale
U.S. Preventive Services Task Force* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-2-200201150-00015 · Cited by 314
Increased Platelet Aggregation in Early Diabetus Mellitus
SAGEL, J., COLWELL, J. A., CROOK, L., & LAIMINS, M. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-6-733 · Cited by 308
Self-citationAronow, W. S., & Ahn, C. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90493-6 · Cited by 301
Gaspoz, J.-M., Coxson, P. G., Goldman, P. A., Williams, L. W., Kuntz, K. M., Hunink, M. G. M., & Goldman, L. (2002) · New England Journal of Medicine · doi:10.1056/nejm200206063462309 · Cited by 290
Increased platelet thromboxane synthesis in diabetes mellitus.
Halushka, P. V., Rogers, R. C., LOADHOLT, C. B., & Colwell, J. A. (1981) · PubMed · Cited by 275
Self-citationDiabetes, Intermittent Claudication, and Risk of Cardiovascular Events: The Framingham Study
Brand, F. N., Abbott, R. D., & Kannel, W. B. (1989) · Diabetes · doi:10.2337/diab.38.4.504 · Cited by 234
Schafer, A. I. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80077-5 · Cited by 158
Effects of Magnesium on Platelet Aggregation and Adhesion
Gawaz, M., Ott, I., Reininger, A. J., & Neumann, F.-J. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648983 · Cited by 138
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s87 · Cited by 127
RIOS, S. M. (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.0280s2014.x · Cited by 101
Ticlopidine Treatment Reduces the Progression of Nonproliferative Diabetic Retinopathy
(1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070130079035 · Cited by 99
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors
Leor, J., Reicher-Reiss, H., Goldbourt, U., Boyko, V., Gottlieb, S., Battler, A., & Behar, S. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00129-1 · Cited by 91
Trial of repeated low-dose aspirin in diabetic angiopathy
DiMinno, G., Silver, M., Cerbone, A. M., & Murphy, S. (1986) · Blood · doi:10.1182/blood.v68.4.886.886 · Cited by 87
Platelet-Leukocyte-Cross-Talk in Diabetes Mellitus
Tschoepe, D., Rauch, U., & Schwippert, B. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979115 · Cited by 76
Mayfield, R. K., Halushka, P. V., Wohltmann, H. J., Lopes-Virella, M. F., Chambers, J. K., LOADHOLT, C. B., & Colwell, J. A. (1985) · Diabetes · doi:10.2337/diab.34.11.1127 · Cited by 71
Self-citationPlatelet cNOS Activity Is Reduced in Patients with IDDM and NIDDM
Bruno, G., Trucco, F., Zumpano, E., Tagliabue, M., Bisceglie, C. D., Pescarmona, G., & Martina, V. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614937 · Cited by 65
Mandal, S., Sarode, R., Dash, S., et al. (1993) · American Journal of Clinical Pathology · doi:10.1093/ajcp/100.2.103 · Cited by 62
Jain, S. K., Krueger, K. S., McVie, R., Jaramillo, J. J., Palmer, M., & Smith, T. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1511 · Cited by 61
Stys, T. P., Lawson, W. E., Smaldone, G. C., & Stys, A. T. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1409 · Cited by 45
Decreased platelet vitamin C in diabetes mellitus: Possible role in hyperaggregation
Sarji, K. E., Kleinfelder, J. S., Brewington, P., Gonzalez, J., Hempling, H. G., & Colwell, J. A. (1979) · Thrombosis Research · doi:10.1016/0049-3848(79)90174-9 · Cited by 39
Self-citationFibrinogen binding and ADP-induced aggregation in platelets from diabetic subjects
Lee, H., Paton, R. C., Passa, P., & Caen, J. (1981) · Thrombosis Research · doi:10.1016/0049-3848(81)90039-6 · Cited by 37
Brand, F. N., Kannel, W. B., Evans, J. C., Larson, M. G., & Wolf, P. A. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70139-5 · Cited by 34
Pahor, M., Psaty, B. M., & Furberg, C. D. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199800004-00004 · Cited by 23
Multifactorial aspects of the treatment of the type II diabetic patient
Colwell, J. A. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90308-5 · Cited by 23
Self-citationThrombotic thrombocytopenic purpura associated with clopidogrel: further evaluation.
Paradiso‐Hardy, F. L., Papastergiou, J., Lanctôt, K. L., & Cohen, E. A. (2002) · PubMed · Cited by 15
Prevention of platelet dysfunction by vitamin E in diabetic atherosclerosis
GERSTER, H. (1993) · Zeitschrift für Ernährungswissenschaft · doi:10.1007/bf01611163 · Cited by 11
Cited by
Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis
Ageno, W., Becattini, C., Brighton, T., Selby, R., & Kamphuisen, P. W. (2008) · Circulation · doi:10.1161/circulationaha.107.709204 · Cited by 974
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Ramírez, C., Sabaté, M., Jimenez-Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2430 · Cited by 538
Angiolillo, D. J., Bernardo, E., Sabaté, M., Jimenez-Quevedo, P., Costa, M. A., Palazuelos, J., Hernández-Antolin, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.049 · Cited by 374
Xu, X. R., Zhang, D., Oswald, B. E., Carrim, N., Wang, X., Hou, Y., Zhang, Q., Lavalle, C., McKeown, T., Marshall, A. H., et al. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2016.1200008 · Cited by 338
Angiolillo, D. J., Bernardo, E., Ramírez, C., Costa, M. A., Sabaté, M., Jimenez-Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.038 · Cited by 310
Metadata
- Authors
- Colwell, J. A., & Nesto, R. W.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2003-07-01
- Volume
- 26
- Issue
- 7
- Pages
- 2181-2188
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2090978392
- Cited by
- 306
- References
- 55
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.